Uploaded November 2025 | Updated September 2026, 1 day ago
On October 29th, 2025, the MIT Club of Northern California brings together clinicians and digital health innovators to explore the real-world lessons emerging from the GLP-1 revolution.
GLP-1 medications like Ozempic and Zepbound have changed the conversation around obesity and metabolic disease, yet they’ve also introduced new challenges:
- How can patients sustain results once they stop medication?
- Why are behavioral and nutritional interventions still essential?
- What are the pitfalls around side effects, supply constraints, and cost?
- And what role should employers and payers play in ensuring access and value?
Join us for an engaging evening of dinner, discussion, and debate as we unpack the clinical, behavioral, and economic realities of GLP-1s, and look ahead to what’s next in obesity and metabolic care.
Whether you’re a patient, healthcare professional, policymaker, or employer, you’ll walk away with a clearer understanding of where the science is headed, how nutrition-first and behavioral approaches fit in, and how we can make the future of obesity care both effective and sustainable.
On October 29th, 2025, the MIT Club of Northern California brings together clinicians and digital health innovators to explore the real-world lessons emerging from the GLP-1 revolution.
GLP-1 medications like Ozempic and Zepbound have changed the conversation around obesity and metabolic disease, yet they’ve also introduced new challenges:
- How can patients sustain results once they stop medication?
- Why are behavioral and nutritional interventions still essential?
- What are the pitfalls around side effects, supply constraints, and cost?
- And what role should employers and payers play in ensuring access and value?
Join us for an engaging evening of dinner, discussion, and debate as we unpack the clinical, behavioral, and economic realities of GLP-1s, and look ahead to what’s next in obesity and metabolic care.
Whether you’re a patient, healthcare professional, policymaker, or employer, you’ll walk away with a clearer understanding of where the science is headed, how nutrition-first and behavioral approaches fit in, and how we can make the future of obesity care both effective and sustainable.
